» Articles » PMID: 22271699

A National Profile of Childhood Epilepsy and Seizure Disorder

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2012 Jan 25
PMID 22271699
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine sociodemographics, patterns of comorbidity, and function of US children with reported epilepsy/seizure disorder.

Methods: Bivariate and multivariable cross-sectional analysis of data from the National Survey of Children's Health (2007) on 91 605 children ages birth to 17 years, including 977 children reported by their parents to have been diagnosed with epilepsy/seizure disorder.

Results: Estimated lifetime prevalence of epilepsy/seizure disorder was 10.2/1000 (95% confidence interval [CI]: 8.7-11.8) or 1%, and of current reported epilepsy/seizure disorder was 6.3/1000 (95% CI: 4.9-7.8). Epilepsy/seizure disorder prevalence was higher in lower-income families and in older, male children. Children with current reported epilepsy/seizure disorder were significantly more likely than those never diagnosed to experience depression (8% vs 2%), anxiety (17% vs 3%), attention-deficit/hyperactivity disorder (23% vs 6%), conduct problems (16% vs 3%), developmental delay (51% vs 3%), autism/autism spectrum disorder (16% vs 1%), and headaches (14% vs 5%) (all P < .05). They had greater risk of limitation in ability to do things (relative risk: 9.22; 95% CI: 7.56-11.24), repeating a school grade (relative risk: 2.59; CI: 1.52-4.40), poorer social competence and greater parent aggravation, and were at increased risk of having unmet medical and mental health needs. Children with prior but not current seizures largely had intermediate risk.

Conclusions: In a nationally representative sample, children with seizures were at increased risk for mental health, developmental, and physical comorbidities, increasing needs for care coordination and specialized services. Children with reported prior but not current seizures need further study to establish reasons for their higher than expected levels of reported functional limitations.

Citing Articles

Therapeutic Drug Monitoring for Lacosamide in Chinese Pediatric Patients with Epilepsy: Focus on Clinical Effectiveness, Tolerability and Drug Interactions.

Mao F, Chen S, Hu Y, Wang S, Chen M, Xu J Int J Med Sci. 2025; 22(5):1150-1157.

PMID: 40027187 PMC: 11866530. DOI: 10.7150/ijms.107660.


Evolving Insights into Prickle2 in Neurodevelopment and Neurological Disorders.

Yang Y, Mao Y, Zhang Y, Xiong T Mol Neurobiol. 2025; .

PMID: 40009262 DOI: 10.1007/s12035-025-04795-8.


ADHD in Adults with Epilepsy: A Guide for Neurologists.

Giambarberi L, Alexander H, Munger Clary H Epilepsy Behav Rep. 2025; 29:100739.

PMID: 39927180 PMC: 11804780. DOI: 10.1016/j.ebr.2024.100739.


The Role of Social Determinants of Health in Childhood Epilepsy.

Jareonsettasin P, Sander J Turk Arch Pediatr. 2025; 60(1):13-21.

PMID: 39803913 PMC: 11736830. DOI: 10.5152/TurkArchPediatr.2025.24271.


Improved effect of EEG-biofeedback intervention on cognitive function in childhood idiopathic epilepsy with ADHD: A retrospective study.

Cheng D, Yang Y, Yan X, Chen Q Heliyon. 2024; 10(23):e40561.

PMID: 39654718 PMC: 11625270. DOI: 10.1016/j.heliyon.2024.e40561.